Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
<h4>Unlabelled</h4>Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early du...
Enregistré dans:
Auteurs principaux: | Thomas Viel, Sonja Schelhaas, Stefan Wagner, Lydia Wachsmuth, Katrin Schwegmann, Michael Kuhlmann, Cornelius Faber, Klaus Kopka, Michael Schäfers, Andreas H Jacobs |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5b83a89cb35d464b98a1abc32bdbe18f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
par: Bin Huang, et autres
Publié: (2021) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
par: Thomas RP, et autres
Publié: (2012) -
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
par: Nadja I. Lorenz, et autres
Publié: (2021) -
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
par: Tae Hoon Roh, et autres
Publié: (2020) -
Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells
par: Selva Rupa Christinal Immanuel, et autres
Publié: (2021)